It is time to include patients with brain tumors in phase I trials in oncology
J Clin Oncol
.
2011 Aug 20;29(24):3211-3.
doi: 10.1200/JCO.2011.36.6328.
Epub 2011 Jul 18.
Authors
Patrick Y Wen
1
,
David Schiff
,
Timothy F Cloughesy
,
David A Reardon
,
Tracy T Batchelor
,
Bruce A Chabner
,
Keith Flaherty
,
John F de Groot
,
Mark R Gilbert
,
Evanthia Galanis
,
Susan M Chang
,
Gary K Schwartz
,
David Peereboom
,
Minesh P Mehta
,
W K Alfred Yung
,
Stuart A Grossman
,
Michael D Prados
,
Lisa M DeAngelis
Affiliation
1
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
[email protected]
PMID:
21768451
PMCID:
PMC4836609
DOI:
10.1200/JCO.2011.36.6328
No abstract available
MeSH terms
Blood-Brain Barrier
Brain Neoplasms / drug therapy*
Clinical Trials, Phase I as Topic / methods*
Humans
Middle Aged
Molecular Targeted Therapy
Grants and funding
U01 CA137443/CA/NCI NIH HHS/United States